Clinical Trials

A Bridging Study of Liposomal Cytarabine-Daunorubicin in Treating Olderly Patients With Treatment-naive High-Risk (Secondary) Acute Myeloid Leukemia

CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.